Vetting of New 2,5-Bis (2,2,2-trifluoroethoxy) Phenyl-Linked 1,3-Thiazolidine-4-one Derivatives as AURKA and VEGFR‑2 Inhibitor Antiglioma Agents Assisted with In Vitro and In Silico Studies

• Sathyanarayana D Shankara,
• Arun M. Isloor,
• Pavan K. Jayaswamy,
• Praveenkumar Shetty,
• Debashree Chakraborty,
• Pushyaraga P. Venugopal

Affiliations

Sathyanarayana D Shankara

Medicinal Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, India

Arun M. Isloor

Medicinal Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, India

Pavan K. Jayaswamy

Central Research Laboratory, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, Karnataka, India

Praveenkumar Shetty

Central Research Laboratory, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, Karnataka, India

Debashree Chakraborty

Biophysical and Computational Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, India

Pushyaraga P. Venugopal

Biophysical and Computational Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Mangalore, India